Osteal Therapeutics

Private

Clinical-stage biopharmaceutical company developing novel therapies for orthopedic infections, including combination treatments for prosthetic joint infections.

Company Info

Sector:Biopharmaceutical

Headquarters:San Diego, California, United States

Founded:2015

Website:www.ostealtx.com/

Upcoming Milestones & Key Dates

2026-Q4

Regulatory

FDA response on combo therapy rejection

Clinical Development Pipeline

Osteal Combination Therapy

Target: Bacterial biofilm

Prosthetic Joint Infections

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Recent News

No recent news updates available for this company.

Leadership Team

Careers & Job Openings

See all open roles

All

San Diego, CA

Apply Now →